Should I admit a child with croup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Admission Criteria for Pediatric Croup

You should admit a child with croup only after they require 3 or more doses of nebulized epinephrine, not the traditional 2 doses, as this approach reduces hospitalizations by 37% without increasing revisits or adverse outcomes. 1, 2

Modern Evidence-Based Hospitalization Criteria

The American Academy of Pediatrics now supports the "3 is the new 2" approach, which represents a significant shift from traditional practice. 2 This updated guideline is based on high-quality 2022 data showing that:

  • Admission rate after ≤2 doses of epinephrine dropped from 6.3% to 1.7% when implementing extended observation protocols 1
  • No increase in 72-hour revisits or ICU transfers occurred with this more conservative approach 1
  • Patients receiving >2 doses still had similar admission rates (81.8% vs 83.3%), confirming that 3 doses is the appropriate threshold 1

Specific Admission Indications

Admit the child when any of the following are present:

  • ≥3 doses of nebulized epinephrine required 2, 3, 4
  • Oxygen saturation <92% on room air 2, 4
  • Age <18 months with severe symptoms 2, 4
  • Respiratory rate >70 breaths/min 2, 4
  • Persistent stridor at rest despite treatment 3
  • Signs of exhaustion, fatigue, or lethargy 2
  • Silent chest or cyanosis (life-threatening signs) 4
  • Family unable to provide appropriate observation at home 4

Critical Observation Protocol After Epinephrine

You must observe the patient for at least 2 hours after each dose of nebulized epinephrine before making any disposition decision. 2, 3, 4 This is non-negotiable because:

  • Epinephrine effects last only 1-2 hours with significant rebound risk 2, 3, 4
  • The observation clock restarts after each subsequent dose 4
  • Discharging before 2 hours is a critical pitfall that can lead to untreated rebound symptoms 2, 3

Safe Discharge Criteria

You can safely discharge the child home when all of the following are met:

  • ≥2 hours since last epinephrine dose without rebound symptoms 4
  • No stridor at rest 2, 4
  • Minimal or no respiratory distress 2, 4
  • Oxygen saturation >92% on room air 4
  • Respiratory rate <50 breaths/min (or <40 in older children) 4
  • Adequate oral intake 2
  • Reliable caregiver able to monitor and return if worsening 2, 4

Common Pitfalls to Avoid

  • Admitting after only 1-2 doses of epinephrine when the child could safely receive a third dose in the ED with appropriate observation 2
  • Discharging within 2 hours of epinephrine administration before assessing for rebound 2, 3
  • Using epinephrine in outpatient settings where immediate return is not feasible 2, 3
  • Failing to provide clear return precautions to parents about worsening stridor, respiratory distress, or inability to maintain hydration 4

Treatment While Deciding on Admission

While observing the patient:

  • Administer oral dexamethasone 0.15-0.6 mg/kg (max 10-12 mg) to all patients regardless of severity 2
  • Provide supplemental oxygen to maintain SpO₂ ≥94% 4
  • Minimize handling to reduce metabolic demands in severely ill children 4
  • Monitor oxygen saturation at least every 4 hours 4
  • Recognize that agitation may signal hypoxemia, not anxiety 4

The key paradigm shift is that most children who previously would have been admitted after 2 doses of epinephrine can now be safely managed with a third dose and extended observation in the ED, reserving admission for those who truly need inpatient monitoring. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Croup in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Croup in Toddlers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.